BrightKaire Featured in kpcw: How a Simple Blood Test Could Transform Depression Care

For millions of people living with depression, finding the right antidepressant can be a long and frustrating process marked by trial and error. In this episode of Cool Science Radio, KPCW speaks with NeuroKaire Chief Medical Officer Dr. Justin Coffey about how BrightKaire™ is helping transform that experience through precision psychiatry.

The discussion explores how BrightKaire uses a simple blood sample to generate patient-specific neurons and applies artificial intelligence to predict an individual's response to antidepressant medications before treatment begins. By providing clinicians with personalized biological insights, the test aims to identify effective treatment options in as little as six to eight weeks, helping reduce unnecessary medication trials and improve patient outcomes.

KPCW’s coverage highlights the growing potential of precision medicine in mental healthcare and NeuroKaire’s mission to replace guesswork with data-driven decision-making for patients living with major depressive disorder.

👉 Read the full article

‍